[1] |
EVANS M,CHUBB B,GUNDGAARD J.Cost-effectiveness of insulin degludec versus insulin glargine in adults with type 1 and type 2 diabetes mellitus[J]. Diabetes Ther,2017,8(2):275-291.
|
[2] |
张杜丹,唐迅,靳丹瑶,等. 中国成年人糖尿病患病率Meta分析[J]. 中华流行病学杂志,2018,39(6):852-857.
|
[3] |
YANG Z M,CHEN L H,HONG M,et al.Serum microRNA profiling and bioinformatics analysis of patients with type 2 diabetes mellitus in a Chinese population[J]. Mol Med Rep,2017,15(4):2143-2153.
|
[4] |
吴爱成,王礼,唐恒锋,等. 2型糖尿病患者25-羟基维生素D与叶酸、同型半胱氨酸的相关性[J]. 检验医学,2017,32(10):849-852.
|
[5] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2017年版)[J]. 中华糖尿病杂志,2018,10(1):4-67.
|
[6] |
闫彬源,张维璐,田敏,等. 1996—2016年中国≥20岁成年人2型糖尿病患病率meta分析[J]. 中华老年多器官疾病杂志,2018,17(11):814-819.
|
[7] |
SHEHATA M M,KAMAL M M,EL-HEFNAWY M H,et al. Association of serum pancreatic derived factor(PANDER) with beta-cell dysfunction in type 2 diabetes mellitus[J]. J Diabetes Complications,2017,31(4):748-752.
|
[8] |
李晓云,王世玉. 维生素D临床应用研究新进展[J]. 重庆医学,2018,47(21):2844-2845.
|
[9] |
张江蓉,袁惠敏,诸培佳,等. 老年2型糖尿病患者血清维生素D水平与同型半胱氨酸及胰岛素敏感性的相关性研究[J]. 中国糖尿病杂志,2017,25(7):615-617.
|
[10] |
刘璐,李晓华. 维生素D3对高脂饲料诱导的小鼠脂肪组织内质网应激以及胰岛素抵抗的影响[J]. 中华内分泌代谢杂志,2017,33(10):861-864.
|
[11] |
KORMAN B D,MARANGONI R G,HINCHCLIFF M,et al.Brief report:association of elevated adipsin levels with pulmonary arterial hypertension in systemic sclerosis[J]. Arthritis Rheumatol,2017,69(10):2062-2068.
|
[12] |
刘慧方. ApoE基因多态性与高脂血症患者血脂代谢的关系[J]. 检验医学,2018,33(11):987-990.
|
[13] |
ZHOU Q,GE Q,DING Y,et al.Relationship between serum adipsin and the first phase of glucose-stimulated insulin secretion in individuals with different glucose tolerance[J]. J Diabetes Investig,2018,9(5):1128-1134.
|
[14] |
VASILENKO M A,KIRIENKOVA E V,SKURATOVSKAIA D A,et al.The role of production of adipsin and leptin in the development of insulin resistance in patients with abdominal obesity[J]. Dokl Biochem Biophys,2017,475(1):271-276.
|
[15] |
周晴,吴锐,葛倩,等. 不同糖耐量人群血清adipsin水平及其与胰岛β细胞功能及胰岛素抵抗的相关性研究[J]. 中华糖尿病杂志,2018,10(6):415-419.
|
[16] |
ELEKOFEHINTI O O,EJELONU O C,KAMDEM J P,et al.Saponins as adipokines modulator:a possible therapeutic intervention for type 2 diabetes[J]. World J Diabetes,2017,8(7):337-345.
|